CervoMed (CRVO) Operating Margin (2023 - 2025)
CervoMed's Operating Margin history spans 8 years, with the latest figure at 2493.79% for Q3 2025.
- For Q3 2025, Operating Margin fell 221560.0% year-over-year to 2493.79%; the TTM value through Sep 2025 reached 441.64%, down 30786.0%, while the annual FY2024 figure was 187.18%, 7783.0% down from the prior year.
- Operating Margin for Q3 2025 was 2493.79% at CervoMed, down from 376.41% in the prior quarter.
- Across five years, Operating Margin topped out at 82.93% in Q2 2023 and bottomed at 2493.79% in Q3 2025.
- The 3-year median for Operating Margin is 175.25% (2023), against an average of 401.87%.
- The largest annual shift saw Operating Margin plummeted -814bps in 2024 before it crashed -221560bps in 2025.
- A 3-year view of Operating Margin shows it stood at 99.59% in 2023, then plummeted by -236bps to 334.91% in 2024, then plummeted by -645bps to 2493.79% in 2025.
- Per Business Quant, the three most recent readings for CRVO's Operating Margin are 2493.79% (Q3 2025), 376.41% (Q2 2025), and 276.55% (Q1 2025).